Hyloris Pharmaceuticals SA (EBR:HYL)
Belgium · Delayed Price · Currency is EUR 5.88
+0.02 (0.34%)
Oct 29, 2025, 4:52 PM CET
Hyloris Pharmaceuticals Market Cap
Hyloris Pharmaceuticals has a market cap or net worth of €164.08 million as of October 29, 2025. Its market cap has decreased by -2.01% in one year.
Market Cap
164.08M
Enterprise Value
146.61M
Revenue
8.46M
Ranking
n/a
PE Ratio
n/a
Stock Price
€5.88
Market Cap Chart
Since June 29, 2020, Hyloris Pharmaceuticals's market cap has decreased from 244.70M to 164.08M, a decrease of -32.95%. That is a compound annual growth rate of -7.22%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 28, 2025 | 164.08M | -10.40% |
| Dec 31, 2024 | 183.12M | -48.71% |
| Dec 29, 2023 | 357.00M | 14.84% |
| Dec 30, 2022 | 310.88M | -30.44% |
| Dec 31, 2021 | 446.90M | 82.11% |
| Dec 31, 2020 | 245.41M | 0.29% |
| Jun 29, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| UCB SA | 46.21B |
| argenx SE | 42.96B |
| Financière de Tubize | 10.19B |
| Fagron NV | 1.53B |
| Ion Beam Applications | 323.69M |
| Onward Medical | 198.85M |
| Nyxoah | 180.63M |
| Sequana Medical NV | 44.88M |